Gavin Zhou of Regenerative Bio @ 2024 Biomarkers of Aging Conference

Gavin Zhou explores the Methylation-based Organ-Level Aging (MOLE) clock and its role in advancing organ-specific anti-aging therapies.
Timestamps
[00:01:27] Translation of biomarkers of aging: value and challenges
[00:02:32] Regenerative Bio: building a closed research-industry loop for translational longevity
[00:04:13] Regenerative Bio: two core platforms and three operational models
[00:06:25] Scheme of methylation-based organ-level aging clock
[00:07:46] MOLE clock vs. existing clocks on GEO and in-house sequencing data
[00:08:23] RevOrgan: anti-aging substance screening platform for oragn-specific anti-aging
[00:09:41] Consumer facing applications of Regenerative Bio, including oral supplements, clinical trials, and Longevity Clinic - La Tip Soh
[00:10:18] Translating biomarkers of aging: the closed loop of assessments and interventions
About Gavin:
Gavin Zhou is the CTO of Regenerative Bio, a longevity company driven by artificial intelligence. Founded in 2021 with the vision of "Health Equity - Empowering Everyone to Age Gracefully and Healthily", the company has developed "Organ-level aging clock" technology and applied it into their platform RevOrgan through precise measurements and effective interventions solutions. Learn more about Regenerative Bio here: / regenerativebio